Stay updated with breaking news from Tim Mccarthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting,... | May 18, 2023
Operator: Good afternoon. Thank you for attending today's Relmada Therapeutics Inc. First Quarter 2023 Earnings Call. My name is Forum , and I will be your moderator for today's call.
In 18-month interim data from ongoing 2-year, Phase 2 Stargardt disease (“STGD1”) trial (“LBS-008-CT02”), we continued to observe that oral Tinlarebant is...
ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows to GBP4.5 million from GBP8.9 million a year... | May 11, 2023
August 2022 Lanstead derivative financial asset of £0.3m Incanthera financial asset of £0.7m Warrants financial asset of... | May 11, 2023